mRNA and Delivery / Lipids and LNP Excipients
DLin-MC3-DMA
Quick view. DLin-MC3-DMA (CAS 1224606-06-7) is listed for identity-scoped inquiry through OROGO. Current availability, exact chemical form, specification and packaging are confirmed for each request; this listing makes no stock or suitability claim. Catalog target purity: Specification by inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Core |
| Reviewed supporting program count | 1 |
| Representative chemistry-platform program | patisiran |
| Highest development phase | Marketed |
| CAS status | Published registry number |
Product profile
DLin-MC3-DMA is classified as mrna and delivery / lipids and lnp excipients (Formula C43H79NO2; molecular weight 642.10).
DLin-MC3-DMA is supplied for research use within the Tertiary Amine Amphiphiles product family.
For DLin-MC3-DMA, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Useful catalog search terms
- 1224606-06-7
Physicochemical data
| Reviewed identity | DLin-MC3-DMA |
|---|---|
| PubChem CID | 49785164 |
| InChI | InChI=1S/C43H79NO2/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-38-42(46-43(45)40-37-41-44(3)4)39-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2/h13-16,19-22,42H,5-12,17-18,23-41H2,1-4H3/b15-13-,16-14-,21-19-,22-20- |
| InChIKey | NRLNQCOGCKAESA-KWXKLSQISA-N |
| SMILES | CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.